The DOI matches its Crossref record; 488 of the 488 references it cites were found in a registry or an index.
Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells
Open accessAbstract
Colon cancer is the third most common cancer worldwide. Most colorectal cancer occurrences are sporadic, not related to genetic predisposition or family history; however, 20–30% of patients with colorectal cancer have a family history of colorectal cancer and 5% of these tumors arise in the setting of a Mendelian inheritance syndrome. In many patients, the development of a colorectal cancer is preceded by a benign neoplastic lesion: either an adenomatous polyp or a serrated polyp. Studies carried out in the last years have characterized the main molecular alterations occurring in colorectal cancers, showing that the tumor of each patient displays from two to eight driver mutations. The ensemble of molecular studies, including gene expression studies, has led to two proposed classifications of colorectal cancers, with the identification of four/five non-overlapping groups. The homeostasis of the rapidly renewing intestinal epithelium is ensured by few stem cells present at the level of the base of intestinal crypts. Various experimental evidence suggests that colorectal cancers may derive from the malignant transformation of intestinal stem cells or of intestinal cells that acquire stem cell properties following malignant transformation. Colon cancer stem cells seem to be involved in tumor chemoresistance, radioresistance and relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 488
Fumagalli, A., Drost, J., Suijkerbuijk, S. J. E., van Boxtel, R., de Ligt, J., Offerhaus, G. J., Begthel, H., Beerling, E., Tan, E. H., Sansom, O. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701219114 · Cited by 258
Sveen, A., Bruun, J., Eide, P. W., Eilertsen, I. A., Ramirez, L., Murumägi, A., Arjama, M., Danielsen, S. A., Kryeziu, K., Elez, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1234 · Cited by 256
Preston, S. L., Wong, W., Chan, A. O., Poulsom, R., Jeffery, R. E., Goodlad, R. A., Mandir, N., Elia, G., Novelli, M. R., Bodmer, W. F., et al. (2003) · PubMed · Cited by 252
Ogino, S., Brahmandam, M., Cantor, M., Namgyal, C., Kawasaki, T., Kirkner, G., Meyerhardt, J. A., Loda, M., & Fuchs, C. S. (2006) · Modern Pathology · doi:10.1038/modpathol.3800482 · Cited by 252
Colorectal cancer: a tale of two sides or a continuum?: Figure 1
Yamauchi, M., Lochhead, P., Morikawa, T., Huttenhower, C., Chan, A. T., Giovannucci, E., Fuchs, C., & Ogino, S. (2012) · Gut · doi:10.1136/gutjnl-2012-302014 · Cited by 250
Imamura, Y., Morikawa, T., Liao, X., Lochhead, P., Kuchiba, A., Yamauchi, M., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., Haigis, K. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3210 · Cited by 249
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function
Storm, E. E., Durinck, S., de Sousa e Melo, F., Tremayne, J., Kljavin, N., Tan, C., Ye, X., Chiu, C., Pham, T., Hongo, J.-A., et al. (2016) · Nature · doi:10.1038/nature16466 · Cited by 249
Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study
Atkin, W., Wooldrage, K., Brenner, A., Martin, J., Shah, U., Perera, S., Lucas, F., Brown, J. P., Kralj-Hans, I., Greliak, P., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30187-0 · Cited by 249
Richman, S. D., Southward, K., Chambers, P., Cross, D., Barrett, J., Hemmings, G., Taylor, M., Wood, H., Hutchins, G., Foster, J. M., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4679 · Cited by 241
O'Rourke, K. P., Loizou, E., Livshits, G., Schatoff, E. M., Baslan, T., Manchado, E., Simon, J., Romesser, P. B., Leach, B., Han, T., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3837 · Cited by 240
Snippert, H. J., Schepers, A. G., van Es, J. H., Simons, B. D., & Clevers, H. (2014) · EMBO reports · doi:10.1002/embr.201337799 · Cited by 239
Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma
Bettington, M., Walker, N., Rosty, C., Brown, I., Clouston, A., McKeone, D., Pearson, S.-A., Leggett, B., & Whitehall, V. (2017) · Gut · doi:10.1136/gutjnl-2015-310456 · Cited by 233
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
Barras, D., Missiaglia, E., Wirapati, P., Sieber, O. M., Jorissen, R. N., Love, C., Molloy, P. L., Jones, I. T., McLaughlin, S., Gibbs, P., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0140 · Cited by 230
Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
Purcell, R. V., Visnovska, M., Biggs, P. J., Schmeier, S., & Frizelle, F. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11237-6 · Cited by 227 · cited 1×
“Interestingly, distinct gut microbiome species are associated with CMS of colorectal cancer; thus, the most highly-enriched microbial species associated with CSM1 included Fusobacterium hwasookii and Porphyromanas gingivalis; and CMS2 was enriched for Selemonas and Prevotella species, while CMS3 had few significant as…”
BackgroundGenomic Profiling of Small-Bowel Adenocarcinoma
Schrock, A. B., Devoe, C. E., McWilliams, R., Sun, J., Aparicio, T., Stephens, P. J., Ross, J. S., Wilson, R., Miller, V. A., Ali, S. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1051 · Cited by 227
Safaee Ardekani, G., Jafarnejad, S. M., Tan, L., Saeedi, A., & Li, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047054 · Cited by 224
ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21
O'Brien, C. A., Kreso, A., Ryan, P., Hermans, K. G., Gibson, L., Wang, Y., Tsatsanis, A., Gallinger, S., & Dick, J. E. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.036 · Cited by 222
Rad, R., Cadiñanos, J., Rad, L., Varela, I., Strong, A., Kriegl, L., Constantino-Casas, F., Eser, S., Hieber, M., Seidler, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.014 · Cited by 216
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers
Salem, M. E., Weinberg, B. A., Xiu, J., El-Deiry, W. S., Hwang, J. J., Gatalica, Z., Philip, P. A., Shields, A. F., Lenz, H.-J., & Marshall, J. L. (2017) · Oncotarget · doi:10.18632/oncotarget.21169 · Cited by 216
Carpentino, J. E., Hynes, M. J., Appelman, H. D., Zheng, T., Steindler, D. A., Scott, E. W., & Huang, E. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1132 · Cited by 215
Krt19+/Lgr5− Cells Are Radioresistant Cancer-Initiating Stem Cells in the Colon and Intestine
Asfaha, S., Hayakawa, Y., Muley, A., Stokes, S., Graham, T. A., Ericksen, R. E., Westphalen, C. B., von Burstin, J., Mastracci, T. L., Worthley, D. L., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.013 · Cited by 209
Mex3a Marks a Slowly Dividing Subpopulation of Lgr5+ Intestinal Stem Cells
Barriga, F. M., Montagni, E., Mana, M., Mendez-Lago, M., Hernando-Momblona, X., Sevillano, M., Guillaumet-Adkins, A., Rodriguez-Esteban, G., Buczacki, S. J. A., Gut, M., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.02.007 · Cited by 207
Characterization of a subpopulation of colon cancer cells with stem cell‐like properties
Chu, P., Clanton, D. J., Snipas, T. S., Lee, J., Mitchell, E., Nguyen, M., Hare, E., & Peach, R. J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24061 · Cited by 204
Yan, H. H. N., Lai, J. C. W., Ho, S. L., Leung, W. K., Law, W. L., Lee, J. F. Y., Chan, A. K. W., Tsui, W. Y., Chan, A. S. Y., Lee, B. C. H., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311849 · Cited by 204
Human Colon Cancer Stem Cells: A New Paradigm in Gastrointestinal Oncology
Boman, B. M., & Huang, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6941 · Cited by 200
Yaeger, R., Shah, M. A., Miller, V. A., Kelsen, J. R., Wang, K., Heins, Z. J., Ross, J. S., He, Y., Sanford, E., Yantiss, R. K., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.001 · Cited by 200
Hung, K. E., Maricevich, M. A., Richard, L. G., Chen, W. Y., Richardson, M. P., Kunin, A., Bronson, R. T., Mahmood, U., & Kucherlapati, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908682107 · Cited by 198
Reconstruction of the Human Colon Epithelium In Vivo
Sugimoto, S., Ohta, Y., Fujii, M., Matano, M., Shimokawa, M., Nanki, K., Date, S., Nishikori, S., Nakazato, Y., Nakamura, T., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.012 · Cited by 196
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
Boutin, A. T., Liao, W.-T., Wang, M., Hwang, S. S., Karpinets, T. V., Cheung, H., Chu, G. C., Jiang, S., Hu, J., Chang, K., et al. (2017) · Genes & Development · doi:10.1101/gad.293449.116 · Cited by 195
Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon
Baker, A.-M., Cereser, B., Melton, S., Fletcher, A. G., Rodriguez-Justo, M., Tadrous, P. J., Humphries, A., Elia, G., McDonald, S. A. C., Wright, N. A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.019 · Cited by 195
Ashton, G. H., Morton, J. P., Myant, K., Phesse, T. J., Ridgway, R. A., Marsh, V., Wilkins, J. A., Athineos, D., Muncan, V., Kemp, R., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.07.015 · Cited by 192
CD44 and EpCAM: Cancer-Initiating Cell Markers
Marhaba, R., Klingbeil, P., Nuebel, T., Nazarenko, I., Buechler, M., & Zoeller, M. (2008) · Current Molecular Medicine · doi:10.2174/156652408786733667 · Cited by 192
MUTYH-associated polyposis (MAP)
Nielsen, M., Morreau, H., Vasen, H. F. A., & Hes, F. J. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.05.011 · Cited by 190
Sansom, O. J., Meniel, V., Wilkins, J. A., Cole, A. M., Oien, K. A., Marsh, V., Jamieson, T. J., Guerra, C., Ashton, G. H., Barbacid, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604130103 · Cited by 187
Leedham, S. J., Graham, T. A., Oukrif, D., McDonald, S. A. C., Rodriguez–Justo, M., Harrison, R. F., Shepherd, N. A., Novelli, M. R., Jankowski, J. A. Z., & Wright, N. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.086 · Cited by 185
Tug-of-war between driver and passenger mutations in cancer and other adaptive processes
McFarland, C. D., Mirny, L. A., & Korolev, K. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404341111 · Cited by 184
Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/β-Catenin Signaling
Moon, B.-S., Jeong, W.-J., Park, J., Kim, T. I., Min, D. S., & Choi, K.-Y. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt373 · Cited by 182
Trinh, A., Trumpi, K., De Sousa E Melo, F., Wang, X., de Jong, J. H., Fessler, E., Kuppen, P. J. K., Reimers, M. S., Swets, M., Koopman, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0680 · Cited by 180
Zeilstra, J., Joosten, S. P. J., Dokter, M., Verwiel, E., Spaargaren, M., & Pals, S. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2940 · Cited by 179
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
Linnekamp, J. F., Hooff, S. R. V., Prasetyanti, P. R., Kandimalla, R., Buikhuisen, J. Y., Fessler, E., Ramesh, P., Lee, K. A. S. T., Bochove, G. G. W., de Jong, J. H., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0011-5 · Cited by 177
Jesinghaus, M., Konukiewitz, B., Keller, G., Kloor, M., Steiger, K., Reiche, M., Penzel, R., Endris, V., Arsenic, R., Hermann, G., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.220 · Cited by 176
Kobayashi, S., Yamada‐Okabe, H., Suzuki, M., Natori, O., Kato, A., Matsubara, K., Jau Chen, Y., Yamazaki, M., Funahashi, S., Yoshida, K., et al. (2012) · STEM CELLS · doi:10.1002/stem.1257 · Cited by 175
Babaei-Jadidi, R., Li, N., Saadeddin, A., Spencer-Dene, B., Jandke, A., Muhammad, B., Ibrahim, E. E., Muraleedharan, R., Abuzinadah, M., Davis, H., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100830 · Cited by 174
Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer
Yeo, H., Betel, D., Abelson, J. S., Zheng, X. E., Yantiss, R., & Shah, M. A. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.06.002 · Cited by 173
Nosho, K., Kure, S., Irahara, N., Shima, K., Baba, Y., Spiegelman, D., Meyerhardt, J. A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.002 · Cited by 172
Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution
Uchi, R., Takahashi, Y., Niida, A., Shimamura, T., Hirata, H., Sugimachi, K., Sawada, G., Iwaya, T., Kurashige, J., Shinden, Y., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005778 · Cited by 172
Tumor Heterogeneity in Colorectal Cancer: What Do We Know So Far?
Sagaert, X., Vanstapel, A., & Verbeek, S. (2018) · Pathobiology · doi:10.1159/000486721 · Cited by 172
Hampel, H., Pearlman, R., Beightol, M., Zhao, W., Jones, D., Frankel, W. L., Goodfellow, P. J., Yilmaz, A., Miller, K., Bacher, J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0104 · Cited by 172
Shaked, H., Hofseth, L. J., Chumanevich, A. P., Chumanevich, A. A., Wang, J., Wang, Y., Taniguchi, K., Gumá, M., Shenouda, S., Clevers, H. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211509109 · Cited by 171
A clinicopathological and molecular analysis of 200 traditional serrated adenomas
Bettington, M. L., Walker, N. I., Rosty, C., Brown, I. S., Clouston, A. D., McKeone, D. M., Pearson, S.-A., Klein, K., Leggett, B. A., & Whitehall, V. L. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.122 · Cited by 171
Rosenberg, D. W., Yang, S., Pleau, D. C., Greenspan, E. J., Stevens, R. G., Rajan, T. V., Heinen, C. D., Levine, J., Zhou, Y., & O'Brien, M. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0343 · Cited by 171
Lal, N., White, B. S., Goussous, G., Pickles, O. J., Mason, M. J., Beggs, A. D., Tanière, P., Willcox, B. E., Guinney, J., & Middleton, G. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1090 · Cited by 170
Molecular genetic profiles of colitis-associated neoplasms
Kern, S. E., Redston, M., Seymour, A. B., Caldas, C., Powell, S. M., Kornacki, S., & Kinzler, K. W. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90167-8 · Cited by 169
Horst, D., Scheel, S. K., Liebmann, S., Neumann, J., Maatz, S., Kirchner, T., & Jung, A. (2009) · The Journal of Pathology · doi:10.1002/path.2597 · Cited by 169
Christie, M., Jorissen, R. N., Mouradov, D., Sakthianandeswaren, A., Li, S., Day, F. L., Tsui, C. S., Lipton, L. R., Desai, J., Jones, I. T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.486 · Cited by 169
Muñoz, N. M., Upton, M., Rojas, A., Washington, M. K., Lin, L., Chytil, A., Sozmen, E. G., Madison, B. B., Pozzi, A., Moon, R. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0890 · Cited by 169
TNIK inhibition abrogates colorectal cancer stemness
Masuda, M., Uno, Y., Ohbayashi, N., Ohata, H., Mimata, A., Kukimoto-Niino, M., Moriyama, H., Kashimoto, S., Inoue, T., Goto, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms12586 · Cited by 168
Laurent‐Puig, P., Pekin, D., Normand, C., Kotsopoulos, S. K., Nizard, P., Perez‐Toralla, K., Rowell, R. K., Olson, J., Srinivasan, P., Corre, D. L., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0983 · Cited by 166
Swindall, A. F., Londoño-Joshi, A. I., Schultz, M. J., Fineberg, N., Buchsbaum, D. J., & Bellis, S. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3424 · Cited by 164
Measuring cancer evolution from the genome
Graham, T. A., & Sottoriva, A. (2017) · The Journal of Pathology · doi:10.1002/path.4821 · Cited by 163
Mouse models of intestinal cancer
Jackstadt, R., & Sansom, O. J. (2015) · The Journal of Pathology · doi:10.1002/path.4645 · Cited by 161
Kim, T.-M., Jung, S.-H., An, C. H., Lee, S. H., Baek, I.-P., Kim, M. S., Park, S.-W., Rhee, J.-K., Lee, S.-H., & Chung, Y.-J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2413 · Cited by 161
Dunne, P. D., McArt, D. G., Bradley, C. A., O'Reilly, P. G., Barrett, H. L., Cummins, R., O'Grady, T., Arthur, K., Loughrey, M. B., Allen, W. L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0032 · Cited by 161
Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity
Wu, Z.-Q., Brabletz, T., Fearon, E., Willis, A. L., Hu, C. Y., Li, X.-Y., & Weiss, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203015109 · Cited by 160
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Fessler, E., Drost, J., van Hooff, S. R., Linnekamp, J. F., Wang, X., Jansen, M., De Sousa E Melo, F., Prasetyanti, P. R., IJspeert, J. E., Franitza, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606184 · Cited by 159
Tong, J., Tan, S., Zou, F., Yu, J., & Zhang, L. (2017) · Oncogene · doi:10.1038/onc.2016.247 · Cited by 159
Bu, P., Wang, L., Chen, K.-Y., Srinivasan, T., Murthy, P. K. L., Tung, K.-L., Varanko, A. K., Chen, H. J., Ai, Y., King, S., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.006 · Cited by 158
Normanno, N., Rachiglio, A. M., Lambiase, M., Martinelli, E., Fenizia, F., Esposito, C., Roma, C., Troiani, T., Rizzi, D., Tatangelo, F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv176 · Cited by 157
Thirlwell, C., Will, O., Domingo, E., Graham, T. A., McDonald, S. A. C., Oukrif, D., Jeffrey, R., Gorman, M., Rodriguez‐Justo, M., Chin‐Aleong, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.033 · Cited by 156
Wu, Z., Wei, D., Gao, W., Xu, Y., Hu, Z., Ma, Z., Gao, C., Zhu, X., & Li, Q. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.016 · Cited by 149
Overexpression of leucine‐rich repeat‐containing G protein‐coupled receptor 5 in colorectal cancer
Uchida, H., Yamazaki, K., Fukuma, M., Yamada, T., Hayashida, T., Hasegawa, H., Kitajima, M., Kitagawa, Y., & Sakamoto, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01571.x · Cited by 149
CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion
Kim, H. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1453 · Cited by 146
Frequent PTPRK–RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma
Sekine, S., Yamashita, S., Tanabe, T., Hashimoto, T., Yoshida, H., Taniguchi, H., Kojima, M., Shinmura, K., Saito, Y., Hiraoka, N., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4709 · Cited by 146
On the abundance of EpCAM on cancer stem cells
Gires, O., Klein, C. A., & Baeuerle, P. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2499-c1 · Cited by 145
Feng, Y., Bommer, G. T., Zhao, J., Green, M. E., Sands, E., Zhai, Y., Brown, K., Burberry, A., Cho, K. R., & Fearon, E. R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.007 · Cited by 145
Carragher, L. A. S., Snell, K. R., Giblett, S. M., Aldridge, V. S. S., Patel, B., Cook, S. J., Winton, D. J., Marais, R., & Pritchard, C. A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000099 · Cited by 144
CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
Chen, S., Song, X., Chen, Z., Li, X., Li, M., Liu, H., & Li, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056380 · Cited by 144
Zaanan, A., Shi, Q., Taı̈eb, J., Alberts, S. R., Meyers, J. P., Smyrk, T. C., Julié, C., Zawadi, A., Tabernero, J. M., Mini, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2899 · Cited by 144
Regan, J. L., Schumacher, D., Staudte, S., Steffen, A., Haybaeck, J., Keilholz, U., Schweiger, C., Golob‐Schwarzl, N., Mumberg, D., Henderson, D. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.025 · Cited by 141
Zeilstra, J., Joosten, S. P. J., van Andel, H., Tölg, C., Berns, A. J. M., Snoek, M., van de Wetering, M., Spaargaren, M., Clevers, H. C., & Pals, S. T. (2013) · Oncogene · doi:10.1038/onc.2012.611 · Cited by 140
The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas
Aust, D. E., Terdiman, J. P., Willenbucher, R. F., Chang, C. G., Molinaro‐Clark, A., Baretton, G. B., Loehrs, U., & Waldman, F. M. (2002) · Cancer · doi:10.1002/cncr.10334 · Cited by 139
Yamamoto, H., Sawai, H., Weber, T. K., Rodrı́guez-Bigas, M. A., & Perucho, M. (1998) · PubMed · Cited by 139
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
Chan, D. L. H., Segelov, E., Wong, R. S., Smith, A., Herbertson, R. A., Li, B. T., Tebbutt, N. C., Price, T. J., & Pavlakis, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007047.pub2 · Cited by 139
Hartmaier, R. J., Albacker, L. A., Chmielecki, J., Bailey, M., He, J., Goldberg, M. E., Ramkissoon, S. H., Suh, J. H., Elvin, J. A., Chiacchia, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2479 · Cited by 139
Early-onset colorectal cancer: A sporadic or inherited disease?
Stigliano, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i35.12420 · Cited by 138
Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneity
McKinley, E. T., Sui, Y., Al‐Kofahi, Y., Millis, B. A., Tyska, M. J., Roland, J. T., Santamaría-Pang, A., Ohland, C., Jobin, C., Franklin, J. L., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93487 · Cited by 136
Holme, Ø., Schoen, R. E., Senore, C., Segnan, N., Hoff, G. S., Løberg, M., Bretthauer, M., Adami, H., & Kalager, M. (2017) · BMJ · doi:10.1136/bmj.i6673 · Cited by 133
A genome editing approach to study cancer stem cells in human tumors
Cortina, C., Turón, G., Stork, D., Hernando‐Momblona, X., Sevillano, M., Aguilera, M., Tosi, S., Merlos‐Suárez, A., Attolini, C. S., Sancho, E., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707550 · Cited by 133
Combined Mutation of Apc, Kras , and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer
Sakai, E., Nakayama, M., Oshima, H., Kouyama, Y., Niida, A., Fujii, S., Ochiai, A., Nakayama, K. I., Mimori, K., Suzuki, Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3303 · Cited by 133
Hyaluronan Facilitates Invasion of Colon Carcinoma Cells in Vitro via Interaction with CD44
Kim, H.-R., Wheeler, M. A., Wilson, C. M., Iida, J., Eng, D. Y., Simpson, M. A., McCarthy, J. B., & Bullard, K. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0202 · Cited by 130
Genetic reconstitution of tumorigenesis in primary intestinal cells
Onuma, K., Ochiai, M., Orihashi, K., Takahashi, M., Imai, T., Nakagama, H., & Hippo, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221926110 · Cited by 130
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
Bae, J. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i5.1457 · Cited by 129
Hamada, T., Cao, Y., Qian, Z. R., Masugi, Y., Nowak, J. A., Yang, J., Song, M., Mima, K., Kosumi, K., Liu, L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.7547 · Cited by 129
Tian, S., Simon, I., Moreno, V., Roepman, P., Tabernero, J., Snel, M., van't Veer, L., Salazar, R., Bernards, R., & Capella, G. (2013) · Gut · doi:10.1136/gutjnl-2012-302423 · Cited by 128
Field Cancerization in the Intestinal Epithelium of Patients With Crohn's Ileocolitis
Galandiuk, S., Rodriguez‐Justo, M., Jeffery, R. E., Nicholson, A. M., Cheng, Y., Oukrif, D., Elia, G., Leedham, S. J., McDonald, S. A. C., Wright, N. A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.12.004 · Cited by 128
Krüppel-Like Factor 4 Acts as an Oncogene in Colon Cancer Stem Cell-Enriched Spheroid Cells
Leng, Z., Tao, K., Xia, Q., Tan, J., Yue, Z., Chen, J., Xi, H., Li, J., & Zheng, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056082 · Cited by 126
Pérez‐Villamil, B., Romera-López, A., Prieto, S. H., López–Campos, G., Calles, A., Asenjo, J. A. L., Sanz‐Ortega, J., Fernández, C., Sastre, J., Alfonso, R., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-260 · Cited by 126
Lin, C., Liao, M.-Y., Lin, W.-W., Wang, Y., Lu, T., & Wu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386235 · Cited by 124
Kantara, C., O’Connell, M. R., Sarkar, S., Moya, S. M., Ullrich, R. L., & Singh, P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3536 · Cited by 124
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Misale, S., Bozic, I., Tong, J., Peraza-Penton, A., Lallo, A., Baldi, F., Lin, K. H., Truini, M., Trusolino, L., Bertotti, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9305 · Cited by 122
Gao, W., Chen, L., Ma, Z., Du, Z., Zhao, Z., Hu, Z., & Li, Q. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.049 · Cited by 122
Roper, J., Tammela, T., Akkad, A., Almeqdadi, M., Santos, S. B., Jacks, T., & Yilmaz, Ö. H. (2018) · Nature Protocols · doi:10.1038/nprot.2017.136 · Cited by 121
The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer
Khan, O. M., Carvalho, J., Spencer‐Dene, B., Mitter, R., Frith, D., Snijders, A. P., Wood, S. A., & Behrens, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97325 · Cited by 121
In situ validation of an intestinal stem cell signature in colorectal cancer
Ziskin, J. L., Dunlap, D. Y., Yaylaoglu, M., Fodor, I. K., Forrest, W. F., Patel, R., Ge, N., Hutchins, G. G. A., Pine, J. K., Quirke, P., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301195 · Cited by 119
Wei, Q., Ye, Z., Zhong, X. Y., Li, L., Wang, C., Myers, R. E., Palazzo, J., Fortuna, D., Yan, A., Waldman, S. A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx278 · Cited by 118
Woischke, C., Schaaf, C. W., Yang, H.-M., Vieth, M. W., Veits, L., Geddert, H., Märkl, B., Stömmer, P. E., Schaeffer, D. F., Frölich, M., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.150 · Cited by 116
Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer
Bramsen, J. B., Rasmussen, M. H., Ongen, H., Mattesen, T. B., Ørntoft, M. W., Árnadóttir, S. S., Sandoval, J., Laguna, T., Vang, S., Øster, B., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.045 · Cited by 114
Lu, M., Huang, C., Pan, M., Chen, H., & Hung, W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0832 · Cited by 112
Langlands, A. J., Almet, A. A., Appleton, P. L., Newton, I. P., Osborne, J. M., & Näthke, I. S. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002491 · Cited by 111
Ohata, H., Ishiguro, T., Aihara, Y., Sato, A., Sakai, H., Sekine, S., Taniguchi, H., Akasu, T., Fujita, S., Nakagama, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3812 · Cited by 110
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis
Bond, C., McKeone, D., Kalimutho, M., Bettington, M. L., Pearson, S., Dumenil, T. D., Wockner, L. F., Burge, M., Leggett, B., & Whitehall, V. (2016) · Oncotarget · doi:10.18632/oncotarget.12130 · Cited by 110
How Dysregulated Colonic Crypt Dynamics Cause Stem Cell Overpopulation and Initiate Colon Cancer
Boman, B. M., Fields, J. Z., Cavanaugh, K. L., Guetter, A. A., & Runquist, O. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2061 · Cited by 108
Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D., Zhang, R., Ebert, M., Chen, J., Wong, B. C., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.137 · Cited by 108
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
Laforest, A., Aparicio, T., Zaanan, A., Pittella-Silva, F., Didelot, A., Desbeaux, A., Corre, D. L., Benhaïm, L., Pallier, K., Aust, D. E., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.007 · Cited by 105
Shenoy, A. K., Fisher, R. C., Butterworth, E. A., Pi, L., Chang, L.-J., Appelman, H. D., Chang, M. N., Scott, E. W., & Huang, E. H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1806 · Cited by 105
Dclk1-expressing tuft cells: critical modulators of the intestinal niche?
Middelhoff, M. A., Westphalen, C. B., Hayakawa, Y., Yan, K. S., Gershon, M. D., Wang, T. C., & Quante, M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00073.2017 · Cited by 105
Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer
Gao, F., Zhang, Y., Wang, S., Liu, Y., Zheng, L., Yang, J., Huang, W., Ye, Y., Luo, W., & Xiao, D. (2014) · Scientific Reports · doi:10.1038/srep03963 · Cited by 104
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis
Sakamoto, N., Feng, Y., Stolfi, C., Kurosu, Y., Green, M. E., Lin, J., Green, M. E., Sentani, K., Yasui, W., McMahon, M., et al. (2017) · eLife · doi:10.7554/elife.20331 · Cited by 104
Takizawa, N., Ohishi, Y., Hirahashi, M., Takahashi, S., Nakamura, K., Tanaka, M., Oki, E., Takayanagi, R., & Oda, Y. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.08.006 · Cited by 103
Inamura, K., Yamauchi, M., Nishihara, R., Kim, S. A., Mima, K., Sukawa, Y., Li, T., Yasunari, M., Zhang, X., Wu, K., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4159-7 · Cited by 103
Characterization of LGR5 stem cells in colorectal adenomas and carcinomas
Baker, A., Graham, T. A., Elia, G., Wright, N. A., & Rodriguez‐Justo, M. (2015) · Scientific Reports · doi:10.1038/srep08654 · Cited by 102
Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
Kemper, K., Versloot, M., Cameron, K., Çolak, S., Melo, F. D. S. E., de Jong, J. H., Bleackley, J., Vermeulen, L., Versteeg, R., Köster, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3066 · Cited by 102
Kopetz, S., McDonough, S. L., Morris, V. K., Lenz, H., Magliocco, A. M., Atreya, C. E., Diaz, L. A., Allegra, C. J., Wang, S. E., Lieu, C. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.4_suppl.520 · Cited by 102
Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine
Rashid, A., & Hamilton, S. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70087-8 · Cited by 101
Li, N., Nakauka‐Ddamba, A., Tobias, J. W., Jensen, S. T., & Lengner, C. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.049 · Cited by 101
Siudeja, K., Nassari, S., Gervais, L., Skorski, P., Lameiras, S., Stolfa, D., Zande, M., Bernard, V., Frio, T. R., & Bardin, A. J. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.09.016 · Cited by 100
Humphries, A., Cereser, B., Gay, L. J., Miller, D. S. J., Das, B., Gutteridge, A., Elia, G., Nye, E. L., Jeffery, R. E., Poulsom, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220353110 · Cited by 100
Sinicrope, F. A., Shi, Q., Allegra, C. J., Smyrk, T. C., Thibodeau, S. N., Goldberg, R. M., Meyers, J. P., Pogue-Geile, K. L., Yothers, G., Sargent, D. J., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5469 · Cited by 99
Klempner, S. J., Gershenhorn, B. G., Tran, P. N., Lee, T. K. M., Erlander, M. G., Gowen, K. A., Schrock, A. B., Morosini, D., Ross, J. S., Miller, V. A., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1192 · Cited by 96
Boman, B. M., Wicha, M. S., Fields, J. Z., & Runquist, O. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100202 · Cited by 95
Lymph Node Metastases in Colon Cancer Are Polyclonal
Ulintz, P., Greenson, J. K., WU, R. T., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1425 · Cited by 95
Yaeger, R., Yao, Z., Hyman, D. M., Hechtman, J. F., Vakiani, E., Zhao, H., Su, W., Wang, L., Joelson, A., Cercek, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0768 · Cited by 94
Dunne, P. D., Alderdice, M., O'Reilly, P. G., Roddy, A. C., McCorry, A. M. B., Richman, S., Maughan, T., McDade, S. S., Johnston, P. G., Longley, D. B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15657 · Cited by 94
A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
Kloosterman, W. P., van den Braak, R. R. J. C., Pieterse, M., van Roosmalen, M. J., Sieuwerts, A. M., Stangl, C., Brunekreef, R., Lalmahomed, Z. S., Ooft, S., van Galen, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3563 · Cited by 94
Kim, J. H., Rhee, Y.-Y., Bae, J. M., Cho, N., & Kang, G. H. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31829ab1c1 · Cited by 92
Diamantopoulou, Z., White, G. R. M., Fadlullah, M. Z. H., Dreger, M., Pickering, K. A., Maltas, J., Ashton, G., MacLeod, R., Baillie, G. S., Kouskoff, V., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.03.007 · Cited by 92
Colonic Crypt Changes during Adenoma Development in Familial Adenomatous Polyposis
Boman, B. M., Walters, R., Fields, J. Z., Kovatich, A. J., Zhang, T., Isenberg, G. A., Goldstein, S. D., & Palazzo, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63407-4 · Cited by 91
PIK3CA and APC mutations are synergistic in the development of intestinal cancers
Deming, D. A., Leystra, A. A., Nettekoven, L. A., Sievers, C. K., Miller, D. L., Middlebrooks, M., Clipson, L. J., Albrecht, D. M., Bacher, J. W., Washington, M. K., et al. (2013) · Oncogene · doi:10.1038/onc.2013.167 · Cited by 91
Computer modeling implicates stem cell overproduction in colon cancer initiation.
Boman, B. M., Fields, J. Z., Bonham-Carter, O., & Runquist, O. A. (2001) · PubMed · Cited by 90
miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1
Sakaguchi, M., Hisamori, S., Oshima, N., Sato, F., Shimono, Y., & Sakai, Y. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0380 · Cited by 90
Takada, M., Zhang, W., Suzuki, A., Kuroda, T. S., Yu, Z., Inuzuka, H., Gao, D., Wan, L., Zhuang, M., Hu, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1240 · Cited by 90
Tsai, J., Liau, J., Lin, Y., Lin, L., Cheng, Y., Cheng, M.-L., & Jeng, Y. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.35 · Cited by 88
Svrcek, M., El-Bchiri, J., Chalastanis, A., Capel, É., Dumont, S., Buhard, O., Oliveíra, C., Seruca, R., Bossard, C., Mosnier, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9744 · Cited by 88
Sinicrope, F. A., Mahoney, M. R., Yoon, H. H., Smyrk, T. C., Thibodeau, S. N., Goldberg, R. M., Nelson, G. D., Sargent, D. J., & Alberts, S. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0527 · Cited by 88
Hierarchy and Plasticity in the Intestinal Stem Cell Compartment
Yousefi, M., Li, L., & Lengner, C. J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.006 · Cited by 87
Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
de Voer, R. M., Hahn, M., Mensenkamp, A. R., Hoischen, A., Gilissen, C., Henkes, A., Spruijt, L., van Zelst-Stams, W. A., Kets, C. M., Verwiel, E. T. P., et al. (2015) · Scientific Reports · doi:10.1038/srep14060 · Cited by 86
NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?
Weren, R. D. A., Ligtenberg, M. J. L., van Kessel, A. G., de Voer, R. M., Hoogerbrugge, N., & Kuiper, R. P. (2017) · The Journal of Pathology · doi:10.1002/path.5002 · Cited by 86
Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis
Chen, H. J., Edwards, R. A., Tucci, S., Bu, P., Milsom, J., Lee, S. H., Edelmann, W., Gumus, Z. H., Shen, X., & Lipkin, S. M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62110 · Cited by 85
STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway
Jin, L., Vu, T., Yuan, G., & Datta, P. K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0286 · Cited by 85
Fusobacterium’s link to colorectal neoplasia sequenced: A systematic review and future insights
Hussan, H., Clinton, S. K., Roberts, K., & Bailey, M. T. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i48.8626 · Cited by 85
Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype
Kanth, P., Bronner, M. P., Boucher, K. M., Burt, R. W., Neklason, D. W., Hagedorn, C. H., & Delker, D. A. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0363 · Cited by 84
Hashimoto, T., Yamashita, S., Yoshida, H., Taniguchi, H., Ushijima, T., Yamada, T., Saito, Y., Ochiai, A., Sekine, S., & Hiraoka, N. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000877 · Cited by 83
Genomic Landscape of Colorectal Mucosa and Adenomas
Borràs, E., Lucas, F. A. S., Chang, K., Zhou, R., Masand, G., Fowler, J., Mork, M. E., You, Y. N., Taggart, M. W., McAllister, F. M., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0081 · Cited by 82
Sekine, S., Mori, T., Ogawa, R., Tanaka, M., Yoshida, H., Taniguchi, H., Nakajima, T., Sugano, K., Yoshida, T., Kato, M., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.39 · Cited by 82
Saito, S., OKABE, H., Watanabe, M., Ishimoto, T., Iwatsuki, M., Baba, Y., Tanaka, Y., Kurashige, J., Miyamoto, Y., & Baba, H. (2013) · Oncology Reports · doi:10.3892/or.2013.2273 · Cited by 81
García-Heredia, J. M., Lucena-Cacace, A., Verdugo‐Sivianes, E. M., Pérez, M., & Carnero, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2358 · Cited by 81
Chandrakesan, P., Weygant, N., May, R. J., Qu, D., Chinthalapally, H. R., Sureban, S. M., Ali, N., Lightfoot, S. A., Umar, S., & Houchen, C. W. (2014) · Oncotarget · doi:10.18632/oncotarget.2393 · Cited by 80
Dong, H.-J., Jang, G.-B., Lee, H., Park, S.-R., Kim, J., Nam, J., & Hong, I. (2016) · Scientific Reports · doi:10.1038/srep22966 · Cited by 80
Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer
Tong, K., Pellón-Cárdenas, O., Sirihorachai, V. R., Warder, B. N., Kothari, O. A., Perekatt, A. O., Fokas, E. E., Fullem, R. L., Zhou, A., Thackray, J. K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.104 · Cited by 80
Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with β-catenin
Fan, X., Wu, H., Yu, H., Zhou, Q., Zhang, Y., & Huang, Q. M. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-0903-z · Cited by 79
Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant
Maddox, J., Shakya, A., South, S., Shelton, D. N., Andersen, J. N., Chidester, S., Kang, J., Gligorich, K. M., Jones, D. A., Spangrude, G. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003048 · Cited by 79
Gene Expression Differences between Colon and Rectum Tumors
Pamplona, R. S., Cordero, D., Berenguer, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1570 · Cited by 79
Clarke, A. R., Cummings, M. C., & Harrison, D. J. (1995) · PubMed · Cited by 79
Alderdice, M., Richman, S. D., Gollins, S., Stewart, P., Hurt, C. N., Adams, R., McCorry, A. M. B., Roddy, A. C., Vimalachandran, D., Isella, C., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5051 · Cited by 78
CD44 Glycoproteins in Colorectal Cancer: Expression, Function, and Prognostic Value
Wielenga, V. T., van der Neut, R., Offerhaus, G. J. A., & Pals, S. T. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60787-3 · Cited by 77
The somatic mutation landscape of premalignant colorectal adenoma
Lin, S., Raju, G. S., Huff, C. D., Ye, Y., Gu, J. H., Chen, J., Hildebrandt, M. A. T., Liang, H., Menter, D. G., Morris, J. S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313573 · Cited by 77
Nakayama, M., Sakai, E., Echizen, K., Yamada, Y., Oshima, H., Han, T.-S., Ohki, R., Fujii, S., Ochiai, A., Robine, S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.194 · Cited by 77
Sadanandam, A., Wang, X., Melo, F. D. S. E., Gray, J. W., Vermeulen, L., Hanahan, D., & Medema, J. P. (2014) · Cell Cycle · doi:10.4161/cc.27769 · Cited by 76
Nikolaev, S. I., Sotiriou, S. K., Pateras, I. S., Santoni, F. A., Sougioultzis, S., Edgren, H., Almusa, H., Robyr, D., Guipponi, M., Saarela, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3869 · Cited by 76
Fujiyoshi, K., Yamamoto, G., Takahashi, A., Arai, Y., Yamada, M., Kakuta, M., Yamaguchi, K., Akagi, Y., Nishimura, Y., Sakamoto, H., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5323 · Cited by 76
Iacopetta, B. J., Welch, J., Soong, R., House, A. K., Zhou, X., & Hamelin, R. (1998) · The Journal of Pathology · Cited by 75
Myant, K., Cammareri, P., Hodder, M. C., Wills, J. C., von Kriegsheim, A., Győrffy, B., Rashid, M., Polo, S., Maspero, E., Vaughan, L. S., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606684 · Cited by 75
Horst, D. A., Kriegl, L., Engel, J., Jung, A., & Kirchner, T. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.004 · Cited by 74
Cereda, M., Gambardella, G., Benedetti, L. G., Iannelli, F., Patel, D., Basso, G., Guerra, R. F., Mourikis, T. P., Puccio, I., Sinha, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12072 · Cited by 74
Sveen, A., Løes, I. M., Alagaratnam, S., Nilsen, G., Høland, M., Lingjærde, O. C., Sørbye, H., Berg, K. C. G., Horn, A., Angelsen, J., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006225 · Cited by 74
Identification, isolation and characterization of human LGR5-positive colon adenoma cells
Dame, M. K., Attili, D., McClintock, S. D., Dedhia, P. H., Ouillette, P. D., Hardt, O., Chin, A. M., Xue, X., Laliberté, J., Katz, E. L., et al. (2018) · Development · doi:10.1242/dev.153049 · Cited by 74
Chen, R., Rabinovitch, P. S., Crispin, D. A., Emond, M. J., Koprowicz, K. M., Bronner, M. P., & Brentnall, T. A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63860-6 · Cited by 73
O’Connell, M. R., Sarkar, S., Luthra, G. K., Okugawa, Y., Toiyama, Y., Gajjar, A. H., Qiu, S., Goel, A., & Singh, P. (2015) · Scientific Reports · doi:10.1038/srep14983 · Cited by 73
Hsieh, J. C. F., Berg, D. V. D., Kang, H., Hsieh, C., & Lieber, M. R. (2013) · Aging Cell · doi:10.1111/acel.12053 · Cited by 72
Kharusi, M. A., Smartt, H. J. M., Greenhough, A., Collard, T. J., Emery, E. D., Williams, A. C., & Paraskeva, C. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt020 · Cited by 72
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
Artells, R., Moreno, I., Díaz, T., Martínez, F., Gel, B., Navarro, A., Ibeas, R., Moreno, J., & Monzó, M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.11.003 · Cited by 71
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer
AIFEG, Sahnane, N., Magnoli, F., Bernasconi, B., Tibiletti, M. G., Romualdi, C., Pedroni, M., de Leòn, M. P., Magnani, G., Bonetti, L. R., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0165-2 · Cited by 71
Zubeldia, I. G., Bleau, A., Redrado, M., Serrano, D., Agliano, A., Gil, C., Vidal‐Vanaclocha, F., Lecanda, J., & Calvo, A. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.004 · Cited by 70
Sakuma, K., Sasaki, E., Kimura, K., Komori, K., Shimizu, Y., Yatabe, Y., & Aoki, M. (2017) · Gut · doi:10.1136/gutjnl-2016-312927 · Cited by 70
Schulmann, K., Mori, Y., Croog, V. J., Yin, J., Olaru, A., Sterian, A., Sato, F., Wang, S., Xu, Y., Deacu, E., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.011 · Cited by 69
Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression
Karagiannis, G. S., Musrap, N., Saraon, P., Treacy, A. D., Schaeffer, D. F., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0221 · Cited by 69
Lewis, A., Segditsas, S., Deheragoda, M. G., Pollard, P. J., Jeffery, R. E., Nye, E. L., Lockstone, H. E., Belnoue-Davis, H. L., Clark, S. K., Stamp, G. W. H., et al. (2010) · Gut · doi:10.1136/gut.2009.193680 · Cited by 67
Kayhanian, H., Goode, E., Sclafani, F., Ang, J. E., Gerlinger, M., de Castro, D. G., Shepherd, S. T. C., Peckitt, C., Rao, S., Watkins, D. J., et al. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.10.006 · Cited by 67
A unifying theory for the crypt
Clevers, H. C. (2013) · Nature · doi:10.1038/nature11958 · Cited by 66
Isolation of Human Colon Stem Cells Using Surface Expression of PTK7
Jung, P., Sommer, C., Barriga, F. M., Buczacki, S. J. A., Hernando‐Momblona, X., Sevillano, M., Duran‐Frigola, M., Aloy, P., Selbach, M., Winton, D. J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.003 · Cited by 66
Giraud, J., Failla, L. M., Pascussi, J., Lagerqvist, E. L., Ollier, J., Finetti, P., Bertucci, F., Ya, C., Gasmi, I., Bourgaux, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1497 · Cited by 66
Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research
Tetteh, P. W., Kretzschmar, K., Begthel, H., van den Born, M., Korving, J., Morsink, F. H. M., Farin, H. F., van Es, J. H., Offerhaus, G. J. A., & Clevers, H. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614057113 · Cited by 66
R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis
Zhou, X., Geng, L., Wang, D., Yi, H., Talmon, G. A., & Wang, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0219 · Cited by 66
Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Repass, J. F., Reproducibility Project: Cancer Biology, Iorns, E. J., Denis, A., Williams, S. R., Perfito, N., & Errington, T. M. (2018) · eLife · doi:10.7554/elife.25801 · Cited by 66
Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
Pamplona, R. S., López‐Doriga, A., Paré, L., Lázaro, K., Bellido, F., Alonso, M. H., Aussó, S., Guinó, E., Beltrán, S., Castro-Giner, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0159 · Cited by 65
Colitis-associated colon cancer: Is it in your genes?
Kraak, L. V. D., Gros, P., & Beauchemin, N. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11688 · Cited by 65
The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers.
Miyazaki, M., Furuya, T., Shiraki, A., et al. (1999) · PubMed · Cited by 64
Landau, M. S., Kuan, S., Chiosea, S. I., & Pai, R. K. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.04.008 · Cited by 64
Olevian, D. C., Nikiforova, M. N., Chiosea, S. I., Sun, W., Bahary, N., Kuan, S., & Pai, R. K. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.11.004 · Cited by 64
Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility
de Voer, R. M., Hahn, M., Weren, R. D. A., Mensenkamp, A. R., Gilissen, C., van Zelst-Stams, W. A., Spruijt, L., Kets, C. M., Zhang, J., Venselaar, H., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005880 · Cited by 64
Cited by
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review
Hossain, M. S., Kader, M. A., Goh, K. W., Islam, M., Khan, M. S., Harun-Ar Rashid, M., Ooi, D. J., Melo Coutinho, H. D., Al-Worafi, Y. M., Moshawih, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865801 · Cited by 346
SOX9 stem-cell factor: clinical and functional relevance in cancer
Aguilar-Medina, M., Avendaño-Félix, M., Lizárraga-Verdugo, E., Bermúdez, M., Romero-Quintana, J. G., Ramos-Payan, R., Ruíz-García, E., & López-Camarillo, C. (2019) · Journal of Oncology · doi:10.1155/2019/6754040 · Cited by 97
Metadata
- Authors
- Testa, U., Pelosi, E., & Castelli, G.
- Venue
- Medical Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-13
- Volume
- 6
- Issue
- 2
- Pages
- 31
- ISSN
- 2076-3271 (ISSN-L)
- OpenAlex
- W2797653557
- Cited by
- 374
- References
- 488
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.